Clinical Trial Update: A Study of Dostarlimab in Participants With Untreated Locally Advanced Rectal Cancer in China [Phase 2]

View source ↗

Summary

GlaxoSmithKline is conducting a Phase 2 study of dostarlimab (Jemperli) in participants with untreated locally advanced rectal cancer in China; the trial status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• JEMPERLI (DOSTARLIMAB)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Rectal | Phase 2 | Status: ACTIVE_NOT_RECRUITING